Moderna (MRNA) is scheduled to announce Q3 earnings results on November 6, before market open, with analysts’ consensus ...

Moderna (MRNA) just began dosing patients in a Phase 1/2 study of mRNA-2808, its experimental T-cell therapy for advanced multiple myeloma. This effort highlights Moderna's growing emphasis on cancer ...

Strand Therapeutics promotes Prashant Nambiar to CSO and appoints Ethan Cash as SVP, Head of Portfolio Management and Program ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

Ionis Pharmaceuticals, Inc. shows promise with new drug launches and a robust pipeline. Click here to read IONS stock ...

For patients with certain types of advanced lung or skin cancer, administration of SARS-CoV-2 mRNA vaccine within 100 days of starting ICIs is associated with increased overall survival.

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

The department said Suzman’s participation highlights the foundation’s long-standing partnership with Biovac and commitment ...

Lipid-based nanoparticles are pivotal in modern medicine, improving drug delivery and mRNA therapies through innovative ...

The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but ...

A study conducted by a multinational research group investigated the potential of audible sound waves (in the form of music, specifically Pink Floyd’s "Another Brick in the Wall, Part 1") in enhancing ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...